论文部分内容阅读
目的 观察新诊断2型糖尿病患者经胰岛素泵强化治疗疗效及机体血清炎性因子影响,分析其临床意义.方法 选取2015年5月-2017年3月平顶山市第二人民医院41例新诊断2型糖尿病患者为研究对象,均给予经胰岛素泵强化治疗,比较其治疗前后本组患者各项指标改善情况.结果 本组患者本组患者经治疗后血糖达标时间(6.7±2.8)、日均胰岛素用量(42.5±6.4)等指标均明显改善,且未发生低血糖情况,此外,较之治疗前,治疗后患者FPG(5.37±0.48)、2hPG(7.41±0.41)、血清hs-CRP(1.75±1.28)、TNF-α(1.81 ±0.21)均明显下降,差异具有统计学意义(P＜0.05).结论 给予2型糖尿病患者(新诊断)使用胰岛素泵强化治疗可达到理想疗效,对患者机体血清炎性因子可起到良好控制与改善作用,应用于临床中安全性得以提升,具有较高应用与推广价值.“,”Objective To observe the effect of intensive treatment of insulin pump and the inflammatory factors of type 2 diabetes mellitus (new diagnosis),and to analyze its clinical significance.Methods A total of 41 newly diagnosed patients with type 2 diabetes mellitus were selected from May 2015 to March 2017 in the Second People's Hospital of Pingdingshan.All patients were treated with intensive insulin pump and compared with those of the patients before and after treatment.Results This group of patients with this group of patients after treatment of blood glucose compliance time (6.7 ± 2.8) Daily insulin consumption (42.5 ± 6.4) and other indicators were significantly improved,and no hypoglycemia,In addition,the levels of serum hs-CRP (1.75 ± 1.28) and TNF-α (1.81 ± 0.21) were significantly lower than those before treatment (P ＜ 0.05),and the difference was statistically significant significance (P ＜ 0.05).Conclusion The use of insulin pump in patients with type 2 diabetes mellitus (new diagnosis) can achieve the desired curative effect,and it can control and improve the serum inflammatory factors of the patients.The safety of the patients can be improved and the application is high with the promotion of value.